As activation of mTOR has been shown to contribute in tumor progression, it can be speculated that the honokiol-induced inhibition of cell proliferation of HNSCC cells is mediated, at least in part, through the downregulation of EGFR/mTOR signaling pathway [51]. This evidence concerns the gene EGFR and head and neck squamous cell carcinoma.